← Back to Clinical Trials
Recruiting NCT04560140

NCT04560140 Promoting Community Reintegration for Young Adults With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04560140
Status Recruiting
Phase
Sponsor Chinese University of Hong Kong
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2021-09-01
Primary Completion 2025-12-31

Trial Parameters

Condition Stroke
Sponsor Chinese University of Hong Kong
Study Type INTERVENTIONAL
Phase N/A
Enrollment 208
Sex ALL
Min Age 18 Years
Max Age 64 Years
Start Date 2021-09-01
Completion 2025-12-31
Interventions
Narrative and Skills-building Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This project will investigate the effects of a Narrative and Skills-building Intervention on young stroke survivors' community reintegration and psychosocial outcomes. A randomised controlled trial will be conducted. This is a novel trial to test the short and long-term effects of a theory-based intervention on young stroke survivors' community reintegration.

Eligibility Criteria

Inclusion Criteria: * (1) are 18-64 years of age, * (2) have a clinical diagnosis of first-ever or recurrent ischaemic or haemorrhagic stroke, * (3) are living at home after discharge from hospital, * (4) have a Montreal Cognitive Assessment score \>20, * (5) have a modified Rankin Scale score ≥3, * (6) can communicate in Cantonese, and * (7) are able to attend all intervention sessions. Exclusion Criteria: * 1\) transient ischaemic attack, subdural or epidural haemorrhage, * 2\) experienced cerebrovascular events due to tumours or head trauma, * 3\) mental condition such as depression, schizophrenia, bipolar or personality disorder, * 4\) incomprehensible speech or difficulty in comprehending conversations, or * 5\) have received a self-management programme in the past.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology